Loading...
Live Verdure Ltd
LV1.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
A$0.92
A$0.00(0.00%)
Live Verdure Ltd (LV1.AX) Financial Performance & Statements
Review Live Verdure Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-12.63%
↓ 12.63%
Operating Income Growth
-332.47%
↓ 332.47%
Net Income Growth
-355.43%
↓ 355.43%
Operating Cash Flow Growth
7.77%
↑ 7.77%
Operating Margin
-647.73%
↓ 647.73%
Gross Margin
35.95%
↑ 35.95%
Net Profit Margin
-666.72%
↓ 666.72%
ROE
-496.41%
↓ 496.41%
ROIC
-475.30%
↓ 475.30%
Live Verdure Ltd (LV1.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Live Verdure Ltd stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $838181.00 | $1.10M | $1.04M | $538613.00 |
| Cost of Revenue | $703458.00 | $536563.00 | $426466.00 | $198649.00 |
| Gross Profit | $134723.00 | $561270.00 | $614160.00 | $339964.00 |
| Gross Profit Ratio | $0.36 | $0.51 | $0.59 | $0.63 |
| R&D Expenses | $793717.00 | $76719.00 | $126687.00 | $126687.00 |
| SG&A Expenses | $6.66M | $5.71M | $2.11M | $930039.00 |
| Operating Expenses | $7.53M | $5.71M | $2.11M | $1.07M |
| Total Costs & Expenses | $8.23M | $6.25M | $2.54M | $1.27M |
| Interest Income | -$6596.00 | $6596.00 | $197.00 | $37513.00 |
| Interest Expense | $67697.00 | $15860.00 | $75224.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $35753.00 | $29168.00 | $14184.00 |
| EBITDA | -$7.40M | -$5.11M | -$1.43M | -$717162.00 |
| EBITDA Ratio | -$6.46 | -$4.66 | -$1.41 | -$1.33 |
| Operating Income | -$7.39M | -$5.15M | -$1.50M | -$731346.00 |
| Operating Income Ratio | -$6.48 | -$4.69 | -$1.44 | -$1.36 |
| Other Income/Expenses (Net) | -$358402.00 | -$9264.00 | -$38427.00 | -$52098.00 |
| Income Before Tax | -$7.75M | -$5.16M | -$1.54M | -$768860.00 |
| Income Before Tax Ratio | -$6.67 | -$4.70 | -$1.48 | -$1.43 |
| Income Tax Expense | $235086.00 | -$235086.00 | $2.00 | $0.00 |
| Net Income | -$7.98M | -$4.92M | -$1.54M | -$768860.00 |
| Net Income Ratio | -$6.67 | -$4.48 | -$1.48 | -$1.43 |
| EPS | -$0.06 | -$0.05 | -$0.02 | -$0.010 |
| Diluted EPS | -$0.06 | -$0.05 | -$0.02 | -$0.010 |
| Weighted Avg Shares Outstanding | $112.30M | $102.62M | $80.29M | $79.99M |
| Weighted Avg Shares Outstanding (Diluted) | $112.30M | $102.62M | $80.29M | $80.15M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan